翰博高新(301321.SZ):主要產品包含背光顯示模組、導光板、精密結構件、光學材料等相關零部件
格隆匯6月18日丨翰博高新(301321.SZ)在投資者互動平台表示,公司為半導體顯示面板重要零部件背光顯示模組一站式綜合方案提供商。公司的主要產品包含背光顯示模組、導光板、精密結構件、光學材料等相關零部件,廣泛應用於筆記本電腦、平板電腦、桌面顯示器、車載屏幕、醫療及工控顯示器、VR等終端產品。公司會緊跟客户需求,與主要面板廠商及終端生產企業就消費電子領域用背光產品開展合作開發和生產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.